Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine

Clinical trial NCT01262924 · COMPLETED

Trial details

NCT number: NCT01262924
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphteria, Tetanus and Pertussis

Start date: 1997-10-01
Primary completion: 1998-12-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.